Search - tctmd.com

Displaying 481 - 500 of 1148

Sort: Relevancy | Date

News Daily News

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Michael O'Riordan

July 07, 2020

A secondary analysis from ASPREE sets up two large RCTs testing statins in an elderly primary-prevention population.

News Daily News

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

Michael O'Riordan

July 06, 2020

News Daily News

Rural-Urban Gap Widens for Cardiometabolic Health Disparities

Michael O'Riordan

June 22, 2020

News Daily News

Had COVID-19? ‘Hidden’ CV Damage Warrants Cautious Return to Physical Activity

Michael O'Riordan

June 17, 2020

News Daily News

Dexamethasone Cuts Death by One-Third in Ventilated COVID-19 Patients

Michael O'Riordan

June 16, 2020

News Daily News

The Color of Coronavirus: Large Burden of COVID-19 Borne by African Americans

Michael O'Riordan

June 12, 2020

News Daily News

PCI for Left Main CAD: Meta-analysis Finds No Increased Risk of Mortality

Michael O'Riordan

June 12, 2020

News Daily News

Myocardial Injury Seen in Over One-Third of Hospitalized COVID-19 Patients

Michael O'Riordan

June 10, 2020

News Daily News

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Michael O'Riordan

June 08, 2020

News Daily News

COVID-19 Upset: Researchers Retract Lancet, NEJM Papers on Hydroxychloroquine, ACEi/ARBs

Michael O'Riordan

June 04, 2020

News Daily News

New EXCEL Analysis Reignites Debate Over PCI for Left Main CAD

Michael O'Riordan

June 01, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Daily News

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

Michael O'Riordan

May 29, 2020

News Daily News

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

Michael O'Riordan

May 27, 2020

News Daily News

Dose of Reality? Hydroxychloroquine and Chloroquine Again Disappoint in COVID-19

Michael O'Riordan

May 26, 2020

News Daily News

Patterns of COVID-19 in Health Professionals Offers Clues for Disease Control

Michael O'Riordan

May 22, 2020

News Daily News

COVID-19 in NYC: CV Risk Factors and Bleak Outcomes in the Critically Ill

Michael O'Riordan

May 19, 2020

News Daily News

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Michael O'Riordan

May 15, 2020

News Daily News

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Michael O'Riordan

May 13, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

Advertisement

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

Rural-Urban Gap Widens for Cardiometabolic Health Disparities

Had COVID-19? ‘Hidden’ CV Damage Warrants Cautious Return to Physical Activity

Dexamethasone Cuts Death by One-Third in Ventilated COVID-19 Patients

The Color of Coronavirus: Large Burden of COVID-19 Borne by African Americans

PCI for Left Main CAD: Meta-analysis Finds No Increased Risk of Mortality

Myocardial Injury Seen in Over One-Third of Hospitalized COVID-19 Patients

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

COVID-19 Upset: Researchers Retract Lancet, NEJM Papers on Hydroxychloroquine, ACEi/ARBs

New EXCEL Analysis Reignites Debate Over PCI for Left Main CAD

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

Dose of Reality? Hydroxychloroquine and Chloroquine Again Disappoint in COVID-19

Patterns of COVID-19 in Health Professionals Offers Clues for Disease Control

COVID-19 in NYC: CV Risk Factors and Bleak Outcomes in the Critically Ill

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content